Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSIP1 | O75475 | 5/20 | 0.59 |
| ▸ | FABP3 | P05413 | 3/20 | 0.59 |
| ▸ | FABP4 | P15090 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.53 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10325642 | 1.00 | PSIP1 (0.59) | PSIP1FABP3FABP4KDM4EFABP5 | |
| SCHEMBL12630063 | 0.88 | PSIP1 (0.56) | PSIP1FABP3FABP4KDM4EPLA2G2A | |
| SCHEMBL12630048 | 0.82 | FABP3 (0.56) | PSIP1FABP3FABP4KDM4EFABP5 | |
| SCHEMBL27703986 | 0.80 | FABP4 (0.65) | FABP3FABP4KDM4EFABP5PLA2G2A | |
| SCHEMBL12630062 | 0.80 | PSIP1 (0.48) | PSIP1FABP3FABP4KDM4EFABP5 | |
| SCHEMBL3321035 | 0.78 | FABP4 (0.62) | FABP3FABP4KDM4EFABP5PLA2G2A | |
| SCHEMBL29985609 | 0.78 | PSIP1 (0.52) | PSIP1 | |
| SCHEMBL12630059 | 0.77 | ALDH1A1 (0.46) | PSIP1FABP3FABP4KDM4EFABP5 | |
| SCHEMBL12630061 | 0.76 | KDM4E (0.42) | PSIP1FABP3FABP4KDM4EFABP5 | |
| SCHEMBL27703988 | 0.75 | FABP4 (0.58) | FABP3FABP4KDM4EFABP5PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220323494-A1 | Novel Control Switch | GLAXOSMITHKLINE IP DEV LTD (GB) | 2022-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220323494-A1 | Novel Control Switch | TNFRSF9, TNFRSF1A, TNFSF11 | PSIP1 1442/4885FABP3 2765/4885FABP4 3354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.